Cell surface modification in the treatment of experimental cancer: neuraminidase or concanavalin A.
D000230:Adenocarcinoma / Q000628:therapy; D000818:Animals; D000951:Antigens, Neoplasm; D002462:Cell Membrane / Q000187:drug effects / Q000276:immunology*; D003208:Concanavalin A / Q000494:pharmacology*; D000939:Epitopes; D005260:Female; D005354:Fibrosarcoma / Q000139:chemically induced / Q000628:therapy; D007167:Immunotherapy / Q000379:methods; D008325:Mammary Neoplasms, Experimental / Q000628:therapy; D008545:Melanoma / Q000628:therapy; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000628:therapy*; D009439:Neuraminidase / Q000494:pharmacology*; D012513:Sarcoma, Experimental / Q000139:chemically induced / Q000628:therapy; D014184:Transplantation, Homologous; D014734:Vibrio cholerae / Q000201:enzymology
D000951:Antigens, Neoplasm; D000939:Epitopes; D003208:Concanavalin A; D009439:Neuraminidase